Drugging non-canonical kinases in cancer therapeutics: Molecular targets, underlying mechanisms and small-molecule inhibitors
Acta Pharmaceutica Sinica B · 2026-07 · 16 (7) · 4196-4232
DOI: 10.1016/j.apsb.2026.03.047 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Acta Pharmaceutica Sinica B, 2026-07. Verfasst von Xuelan Ma und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center of Infectious Diseases, Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan Universit…. Die Arbeit nennt 255 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Sichuan University, Natural Science Foundation of Sichuan Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center of Infectious Diseases, Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China.
- Institute of Precision Drug Innovation and Cancer Center, Second Affiliated Hospital of Dalian Medical University, Dalian 116023, China.
- Department of Neurosurgery, The First Hospital of China Medical University, Shenyang 110001, China.
Förderung
- National Natural Science Foundation of China
- Sichuan University
- Natural Science Foundation of Sichuan Province
Zitieren
APA
Ma, X., Wen, Z., Wang, Z., Peng, Z., Wu, D., Wang, J., & Liu, B. (2026). Drugging non-canonical kinases in cancer therapeutics: Molecular targets, underlying mechanisms and small-molecule inhibitors. Acta Pharmaceutica Sinica B, 16(7), 4196-4232. https://doi.org/10.1016/j.apsb.2026.03.047
Vancouver
Ma X, Wen Z, Wang Z, Peng Z, Wu D, Wang J, et al. Drugging non-canonical kinases in cancer therapeutics: Molecular targets, underlying mechanisms and small-molecule inhibitors. Acta Pharmaceutica Sinica B. 2026;16(7):4196-4232. doi:10.1016/j.apsb.2026.03.047
BibTeX
@article{Ma2026,
author = {Ma, Xuelan and Wen, Zhifeng and Wang, Zhiwen and Peng, Zhiqi and Wu, Dongbo and Wang, Jun and Liu, Bo},
title = {Drugging non-canonical kinases in cancer therapeutics: Molecular targets, underlying mechanisms and small-molecule inhibitors},
journal = {Acta Pharmaceutica Sinica B},
year = {2026},
volume = {16},
number = {7},
pages = {4196--4232},
doi = {10.1016/j.apsb.2026.03.047}
}
EUVIMED